Number of Shares
-115,781.00
Current Holdings Value*
$-10.27 Mil
% of Portfolio
-27.07%
Total Estimate Gain
$8.79 Mil
% of Total Estimate Gain
185.53%

K2 Alternative Strategies Fund's SPDR Biotech ETF Holding Summary

As of 2025-02-28, K2 Alternative Strategies Fund held -115,781.00 shares of SPDR Biotech ETF(XBI), totaling $-10.27 Mil. This investment constitutes -27.07% of their stock portfolio, and K2 Alternative Strategies Fund now holds -0.18% of the outstanding SPDR Biotech ETF(XBI) stock.

The initial trade took place in 2023Q4. And since then K2 Alternative Strategies Fund has made 2 purchases of XBI, at an average price of $91.74, for a total of 51,615.00 shares. In addition, there have been 4 sales at an average price of $80.77 for 167,396.00 shares. Based on historical transaction data and XBI's current price of $80.89, K2 Alternative Strategies Fund's estimated gain on his XBI holdings is $8.79 Mil, reflecting a 185.53% gain to date.

K2 Alternative Strategies Fund XBI ($80.89) Holding Chart

K2 Alternative Strategies Fund XBI ($80.89) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1